4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-060754
CBO & EVP sold 286 shares at $81.14 ($23,206)
From the SEC's structured data for this filing
Trades in this filing
Kassberg Thomas Richard · CBO & EVP
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-10-14 | Sale : show line 1 in the form | −286 | $81.14 | $23,206 | 216,266 | D |
| Open-market sales · 286 sh · avg $81.14 · $23,206 | ||||||
Loading xslF345X03/doc4.xml…